Mosaic ImmunoEngineering (CPMV) Other financing activities (2010 - 2011)
Mosaic ImmunoEngineering (CPMV) posted quarterly Other financing activities of -$1090.0 for Q2 2011, down 72.2% quarter-over-quarter from -$633.0 in Q1 2011.
Mosaic ImmunoEngineering (CPMV) Other financing activities (2010 - 2011) Analysis & Trends
Mosaic ImmunoEngineering's Other financing activities history runs 2 years deep, the most recent figure standing at -$1090.0 for Q2 2011.
- In Q2 2011, Other financing activities changed N/A year-over-year to -$1090.0; the TTM figure through Feb 2018 stood at -$1723.0 (changed 0.0% YoY), while the FY2013 annual figure was -$7500.0, changed N/A from the prior year.
- Other financing activities for Q2 2011 stood at -$1090.0, down from -$633.0 in the prior quarter.
- The five-year high for Other financing activities was -$633.0 in Q1 2011, with the low at -$2082.0 in Q3 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Mosaic ImmunoEngineering | 527,536.97 | 527,536.97 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2011 | -1,090.00 |
| May 31, 2011 | -1,090.00 |
| Feb 28, 2011 | -633.00 |
| Feb 28, 2011 | -633.00 |
| Aug 31, 2010 | -2,082.00 |
| Aug 31, 2010 | -2,082.00 |